BRADFORD PATRICIA A 4

What Happened
Patricia A. Bradford, a director of Phio Pharmaceuticals Corp. (PHIO), received a grant of 18,500 restricted stock units (RSUs) on 2026-02-05. The RSUs were reported at a $0.00 acquisition price (typical for compensation awards); they represent a future right to common shares and are not an immediate purchase or sale.

Key Details

• Transaction type: Award/Grant of RSUs (code A)
• Transaction date: 2026-02-05; Form 4 filed 2026-02-06 (timely)
• Quantity: 18,500 RSUs; reported price: $0.00
• Vesting: Per footnote, these RSUs vest on the first annual anniversary of the grant (F1)
• Other footnotes: F2 notes the total holdings include shares underlying unvested RSUs; F3 indicates the reported numbers were adjusted for prior reverse stock splits
• Shares owned after transaction: Not specified in the provided filing excerpt

Context
RSUs are a common form of equity compensation: they convert into actual shares only after vesting and typically cannot be sold until vested. This award is a compensation grant to a director rather than a market purchase (which some investors view as a more direct bullish signal). No sale, exercise, or 10b5-1 plan is indicated in this filing.